manidipine has been researched along with Symptom Cluster in 1 studies
Excerpt | Relevance | Reference |
---|---|---|
"Manidipine is a lipophilic, third-generation, highly vasoselective, dihydropyridine (DHP) calcium channel antagonist, which, when given on a once-daily basis, effectively reduces blood pressure (BP) in patients with mild-to-moderate essential hypertension." | 4.82 | Antihypertensive effect of manidipine. ( Roca-Cusachs, A; Triposkiadis, F, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Roca-Cusachs, A | 1 |
Triposkiadis, F | 1 |
1 review available for manidipine and Symptom Cluster
Article | Year |
---|---|
Antihypertensive effect of manidipine.
Topics: Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channe | 2005 |